Increase Quality of Care Archives - Page 11 of 17

DPC Comments on 2016 Prospective Payment System and QIP

Hannah Bracamonte2024-03-29T01:50:32+00:00September 16th, 2015|Categories: Comment Letter, Quality Incentive Program|

DPC recently sent a comment letter responding to the proposed payment rule for CMS’s Medicare End Stage Renal Disease program. Using responses from our 2015 Patient Survey, our suggestions focus on how CMS can improve on the key issues of payment and quality for patients. On the payment side, we urge CMS to revise its patient-level payment system by focusing on individuals’ experiences, instead of drawing conclusions based off of large amounts of data. Better support of rural facilities and home dialysis is also important, providing more access and opportunity for treatment. On the quality front, we suggest changes be [...]

Report Finds Star Rating System Does Not Follow Federal Guidelines

Hannah Bracamonte2024-03-29T01:50:32+00:00August 14th, 2015|Categories: 5-Star Ratings, Article, Uncategorized|

The Medicare five-star rating system, maintained by the Center for Medicaid and Medicare Services’ (CMS), has recently come under scrutiny by the Center for Regulatory Effectiveness (CRE). In a letter from last month, CRE officials report that multiple entities have contacted them about the system possibly violating federal regulations. According to the letter, data from the rating system helps in determining rebates, eligibility and bonuses for patients. Current law requires this information be posted on a federal register to receive comments from stakeholders. CRE officials found CMS has instead been posting the information on their website and providing only summaries of comments. [...]

Biosimilar Medication Topic of House Letter to CMS

Hannah Bracamonte2024-03-29T01:50:32+00:00August 14th, 2015|Categories: Improve Access to Care, Increase Quality of Care, Promote Financial Security|

When the FDA approves a generic drug, it’s based on the chemicals contained in the original brand medication. Congress recently enacted a similar process for the approval of “biosimilars” based on the original biologic medication. The main difference is that the “biosimilar” is approved based on its development process. Biosimilars have the potential to be a cheaper alternative for expensive biologic medications such as Epogen, a drug used for anemia management. A letter sent from the House of Representatives to the Centers for Medicaid and Medicare Services (CMS) calls attention to a biosimilar reimbursement proposal in CMS’s 2016 Medicare Physician Fee Schedule proposed [...]

Chronic Kidney Disease Improvement in Research and Treatment Act Gaining Momentum

Hannah Bracamonte2024-03-29T01:50:33+00:00May 14th, 2015|Categories: Care Coordination, Dialysis Funding, Medicare Advantage, Promote Financial Security|

While only a few weeks after its introduction, the Chronic Kidney Disease Improvement in Research and Treatment Act (H.R. 1130/S. 598) is gaining new cosponsors in Congress. That said, we still have a lot of work to do to ensure this legislation is signed into law. If you want to see better care for dialysis patients, please take a few minutes to contact your Members of Congress and urge them to support this important legislation by clicking here. Representatives Tom Marino (R-PA), John Lewis (D-GA) and Peter Roskam (R-IL) introduced H.R. 1130 as the bill’s original sponsors. They are now joined [...]

Dialysis Patient Citizens’ Statement of Principles to Guide Formulation of Star Ratings

Hannah Bracamonte2024-03-29T01:50:33+00:00April 21st, 2015|Categories: 5-Star Ratings, Article|

Dialysis Patient Citizens (DPC) endorses the following six principles to guide formulation of star ratings for Dialysis Facility Compare: Star ratings must use metrics that represent aspects of care that are important to patients. Star ratings should not simply rely upon any information that happens to be available; patient priorities should be ascertained and reflected in the ratings. Star ratings must drive improvement. Facilities should be held to absolute standards. They must be able to improve their scores through improved quality regardless of how competing facilities perform. Competition among facilities should be realistic, e.g., facilities in regions with generally poor health [...]

DPC Board Members to Serve on Three Technical Expert Panels

Hannah Bracamonte2024-03-29T01:50:33+00:00April 7th, 2015|Categories: 5-Star Ratings, Access to Transplant, Treatment Options|

The Centers for Medicare and Medicaid Services (CMS) regularly schedules technical expert panels (TEPs) to advise the agency on quality measures. In the words of CMS, a TEP is “a group of stakeholders and experts who provide technical input…on the development, selection, and maintenance of measures for which CMS contractors are responsible.” CMS is contracting with the University of Michigan Kidney Epidemiology and Cost Center (UM-KECC) to host a TEP on the Dialysis Facility Compare star rating system. While the complete roster of participants is not public yet, we are pleased to announce that DPC Interim President Jack Reynolds was selected [...]

Urge Your Members of Congress to Take Action During National Minority Health Month

Hannah Bracamonte2024-03-29T01:50:33+00:00April 7th, 2015|Categories: Care Coordination, Dialysis Funding, Medicare Advantage|

April is National Minority Health Month, an issue of vital importance for dialysis patients since even greater health disparities are reflected in the dialysis patient community. For example, African Americans are 3.5 times more likely to develop kidney failure than non-Hispanic white Americans, Hispanic Americans are 1.5 times more likely and Native Americans are 1.7 times more likely. Asian Americans are also more likely to develop kidney failure. Click here to urge your Members of Congress to co-sponsor the Chronic Kidney Disease Improvement in Research and Treatment Act (S. 598 and H.R. 1130), which includes a key provision supporting research on kidney health [...]

Permanent Medicare Physician Payment Increase Passes Congress

Hannah Bracamonte2024-03-29T01:50:33+00:00April 7th, 2015|Categories: Dialysis Funding, Medigap Coverage|

Congress recently passed the Medicare Access and CHIP Reauthorization Act, also known as the permanent “doc fix” bill. The bill passed the House of Representatives 392-37 and the Senate 92-8, with strong bipartisan support. The White House has announced President Obama’s intent to sign the bill into law. Those who voted in favor of the bill felt it was necessary to permanently replace the current Medicare physician payment formula. In 1997, Congress passed a formula known as the sustainable growth rate (SGR) formula, which unexpectedly dictated regular pay cuts for doctors. In 2003, many in Congress began to fear that the [...]

What are Dialysis Patients’ Priorities for Quality Information? Insights from DPC Patient Survey

Hannah Bracamonte2024-03-29T01:50:33+00:00March 11th, 2015|Categories: 5-Star Ratings, Article, Quality Incentive Program|

After the Centers for Medicare and Medicaid Services (CMS) announced its plans to release the Dialysis Facility Compare star rating system, DPC began to discuss with its membership what would make such a rating system successful. The two areas that DPC’s Board Members, Patient Ambassadors and membership all rated highest were 1) staff respect/listening and 2) patient education. Staff Respect/Listening: This topic compresses two questions from the annual Consumer Assessment of Healthcare Providers and Systems (CAHPS) questionnaire that Medicare requires dialysis patients to complete. It was even more apparent during our focus group discussions of our survey responses how upset [...]

Urge Your Members of Congress to Co-Sponsor the Chronic Kidney Disease Improvement in Research and Treatment Act!

Hannah Bracamonte2024-03-29T01:50:33+00:00March 11th, 2015|Categories: Care Coordination, Dialysis Funding, Medicare Advantage|

Senators Ben Cardin (D-MD), Mike Crapo (R-ID) and Bill Nelson (D-FL) were joined by Representatives Tom Marino (R-PA), John Lewis (D-GA) and Peter Roskam (R-IL) in introducing the Chronic Kidney Disease Improvement in Research and Treatment Act (S. 598/H.R. 1130) to improve the health of kidney patients. If passed, this bill would provide access to Medicare Advantage (MA) plans for dialysis patients. This bill would also enhance current research efforts related to chronic kidney disease (CKD) by: Requiring the Government Accountability Office (GAO) to calculate the overall cost of CKD care, ensure that federal funding for CKD research is appropriate relative to [...]

Dialysis Patient Citizens

Recent News